Impact of the 2009 Influenza A (H1N1) Pandemic on Healthcare Workers at a Tertiary Care Center in New York City

2013 ◽  
Vol 34 (8) ◽  
pp. 825-831 ◽  
Author(s):  
Nahid Bhadelia ◽  
Rajiv Sonti ◽  
Jennifer Wright McCarthy ◽  
Jaclyn Vorenkamp ◽  
Haomiao Jia ◽  
...  

Background and Objective.Assessing the impact of 2009 influenza A (H1N1) on healthcare workers (HCWs) is important for pandemic planning.Methods.We retrospectively analyzed employee health records of HCWs at a tertiary care center in New York City with influenza-like illnesses (ILI) and confirmed influenza from March 31, 2009, to February 28, 2010. We evaluated HCWs' clinical presentations during the first and second wave of the pandemic, staff absenteeism, exposures among HCWs, and association between high-risk occupational exposures to respiratory secretions and infection.Results.During the pandemic, 40% (141/352) of HCWs with ILI tested positive for influenza, representing a 1% attack rate among our 13,066 employees. HCWs with influenza were more likely to have fever, cough, and tachycardia. When compared with the second wave, cases in the first wave were sicker and at higher risk of exposure to patients' respiratory secretions (P = .049). HCWs with ILI- with and without confirmed influenza-missed on average 4.7 and 2.7 work days, respectively (P = .001). Among HCWs asked about working while ill, 65% (153/235) reported they did so (mean, 2 days).Conclusions.HCWs in the first wave had more severe ILI than those in the second wave and were more likely to be exposed to patients' respiratory secretions. HCWs with ILI often worked while ill. Timely strategies to educate and support HCWs were critical to managing this population during the pandemic.

2020 ◽  
Vol 159 (5) ◽  
pp. 1962-1964
Author(s):  
Michael T. Dolinger ◽  
Nikhil A. Kumta ◽  
David A. Greenwald ◽  
Marla C. Dubinsky

2012 ◽  
Vol 13 (4) ◽  
pp. 375-380 ◽  
Author(s):  
J. Scott Baird ◽  
Amanda Buet ◽  
Saul R. Hymes ◽  
Thyyar M. Ravindranath ◽  
Sheemon Zackai ◽  
...  

2020 ◽  
Vol 31 (4) ◽  
pp. 759
Author(s):  
Elayaperumal Indhumathi ◽  
Vamsi Krishna Makkena ◽  
Varun Mamidi ◽  
Varadharajan Jayaprakash ◽  
Matcha Jayakumar

BMJ Open ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. e044526
Author(s):  
Gurchetan Randhawa ◽  
Kunzah A Syed ◽  
Kavish Singh ◽  
Sanchit V Kundal ◽  
Sharad Oli ◽  
...  

ObjectivesTo determine if obesity and diabetes are risk factors for severe outcomes in COVID-19 and to compare patient outcomes in those two conditions.DesignRetrospective cohort study.SettingUrban tertiary care center in New York City.Participants302 patients admitted in an inpatient setting, ≥18 years old, with a laboratory-confirmed diagnosis of COVID-19 via nasal PCR swab were randomly selected. Patients were separated into two cohorts based on their body mass index and hemoglobin A1c. 150 patients were placed in the non-obese, non-diabetic cohort and 152 patients were placed in the corresponding cohort (obesity alone, obesity and diabetes, and diabetes alone).MeasurementsPrimary outcomes were development of acute kidney injury, commencement of renal replacement therapy, aminotransferase elevation, troponin elevation, lactic acidosis, development of septic shock, use of vasopressors, presence of acute respiratory distress syndrome (ARDS) and intubation. The secondary outcomes were length of stay in days and mortality.ResultsPatients with obesity and/or diabetes were more likely to develop ARDS (79 patients vs 57 patients, p<0.0001) and to be intubated (71 patients vs 45 patients, p=0.0031). Patients with obesity and/or diabetes were more likely to require vasopressors (60 patients vs 41 patients, p=0.0284) and to develop lactic acidosis (median 3.15 mmol/L, IQR 1.8 to 5.2 mmol/L, p=0.0432). When comparing patients with diabetes with and without obesity against patients with obesity alone, they were more likely to develop ARDS (87.5%, p=0.0305). Despite these findings, there was no difference in mortality.ConclusionsIn patients hospitalised with COVID-19, those with obesity and/or diabetes were more likely to suffer severe complications, but had negligible differences in mortality. This highlights the importance of close monitoring of patients with these conditions and additional areas of research needed to explain the mortality findings.


2010 ◽  
Vol 201 (7) ◽  
pp. 984-992 ◽  
Author(s):  
Anne Marie France ◽  
Michael Jackson ◽  
Stephanie Schrag ◽  
Michael Lynch ◽  
Christopher Zimmerman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document